C9 and amyotrophic lateral sclerosis: Nf‐ICs levels were higher in C9+ve ALS patients compared to HC‐1 and ALS‐F (Fig. 1H, p = 0.022 and p = 0.030), suggesting that the expression of this marker may be influenced by the C9orf72 genetic status and not by the rate of disease progression.